Company intelligence / Profile preview

Foster Group

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Foster Corporation supplies custom polymer compounds used in FDA Class I–III medical devices. Its expertise includes radiopaque fillers, implantable-grade polymers, drug/polymer blends for controlled release or long-term implants, and value-added supply chain solutions. It operates three ISO 13485:2016-certified facilities supporting formulation through production. Its former subsidiary/division Foster Delivery Science specialized in hot melt extrusion-based drug delivery platforms before being acquired by Sever Pharma Solutions.

Modalities: Drug/polymer blends for implantable drug delivery systemsPolymer-based materials for medical devices and implants
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Foster Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Foster Group.

Explore the full profile